The Future of Psychedelics in Alzheimer Disease Treatment
Ixtlan Bioscience is an Israeli based biotech company working with natural psilocybin mushrooms in the field of Alzheimer and dementia diseases. We utilize proprietary growing, extraction and formulation capabilities to create an affordable, comfortable and easy to use treatment option in the form of a therapeutical kit.
To take part in the global endeavor of Alzheimer and dementia diseases by contributing our novel psilocybin formulations while simultaneously conducting research and collecting data through continuous patient derived feedback.
Affecting positive large scale change in the mental health field by focusing on novel and safe drug treatment protocols that address core issues and not solely symptom suppression.
FROM PRECLINICAL DEVELOPMENT
TO CLINICAL VALIDATION
Creating naturally derived psilocybin formulations for the mental
health industry by controlling the process from spore production to diverse compound extractions.